Literature DB >> 8088760

Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay.

P Roger1, P Montcourrier, T Maudelonde, J P Brouillet, A Pages, F Laffargue, H Rochefort.   

Abstract

High cathepsin D (cath-D) concentration in breast cancer cytosol is associated with increased risk of metastasis. To specify the relative contribution of the different cells types responsible for cath-D level in cytosol, we validated semiquantitative cath-D immunoperoxidase staining on formalin-fixed, paraffin-embedded sections, using the M1G8 monoclonal antibody, one of the two antibodies of the cytosolic assay. Using computer-aided image analysis, cath-D level in cancer cells was estimated by integrating both staining intensity in each cell and proportion of stained cells. We confirmed on 41 primary breast cancers a higher expression of cath-D in cancer cells compared with peritumoral mammary glands. Cancer cell staining was mostly in lysosomes and for some invasive ductal carcinomas in large vesicles corresponding to phagosomes. Lymphocytes and fibroblasts were not or were only weakly stained. Macrophages also were stained for cath-D, generally on the periphery of the tumor area. The cytosolic cath-D level was correlated with cath-D expression in cancer cells (r = .76; P = 1 x 10(-4)) rather than with the number of macrophages in the tumor (r = .29; P = .09), as determined by use of the specific anti-CD68 antibody. There was a significant increase in the tissue cath-D level in tumors containing large vesicles compared with tumors without large vesicles. This approach provides a means to separately estimate the prognostic significance of cath-D expression in cancer cells and macrophages when evaluating risk of metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088760     DOI: 10.1016/0046-8177(94)90004-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

Authors:  C Charpin; S Garcia; C Bouvier; F Martini; M Lavaut; C Allasia; P Bonnier; L Andrac
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

2.  Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.

Authors:  C Escot; Y Zhao; C Puech; H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

4.  Cathepsin B and D are Localized at the Surface of Human Breast Cancer Cells.

Authors:  Mansoureh Sameni; Edith Elliott; Grace Ziegler; Philip H Fortgens; Clive Dennison; Bonnie F Sloane
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

5.  Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.

Authors:  Daniel E Abbott; Naira V Margaryan; Jacqueline S Jeruss; Seema Khan; Virginia Kaklamani; David J Winchester; Nora Hansen; Alfred Rademaker; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2010-01-15       Impact factor: 4.742

6.  Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

Authors:  G Ferrandina; G Scambia; F Bardelli; P Benedetti Panici; S Mancuso; A Messori
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Prospective evaluation of prognostic factors in operable breast cancer.

Authors:  R A Hawkins; A L Tesdale; M E Killen; W J Jack; U Chetty; J M Dixon; M J Hulme; R J Prescott; M A McIntyre; W R Miller
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

8.  Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.

Authors:  G Ferrandina; G Scambia; A Fagotti; G D'Agostino; P Benedetti Panici; A Carbone; S Mancuso
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

9.  Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.

Authors:  A Lösch; P Kohlberger; G Gitsch; A Kaider; G Breitenecker; C Kainz
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

10.  Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.

Authors:  J A Foekens; M P Look; J Bolt-de Vries; M E Meijer-van Gelder; W L van Putten; J G Klijn
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.